Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00443001 · ClinicalTrials.gov registry record · NA

Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias

A NA study, sponsored by GE Healthcare.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT00443001: Completed NA study, sponsored by GE Healthcare.

NCT00443001 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00443001, a NA study, has completed, sponsored by GE Healthcare.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This protocol focuses on the evaluation of the GE noninvasive blood pressure parameter in subjects with dysrhythmias and normal sinus rhythm. The study follows the recommendations of the ANSI/AAMI SP10 Standard.

Interventions

  • DEVICE Non invasive blood pressure monitor

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2007-04
Est. Completion 2007-07
Phase NA
GE Healthcare

99 total trials

What the finished NCT00443001 record still lists

NCT00443001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Non invasive blood pressure monitor is the first listed.

NCT00443001 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00443001 about?

NCT00443001 is a clinical study titled "Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias". This protocol focuses on the evaluation of the GE noninvasive blood pressure parameter in subjects with dysrhythmias and normal sinus rhythm. The study follows the recommendations of the ANSI/AAMI SP10 Standard.

What is the current status of trial NCT00443001?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-04. Estimated completion is 2007-07.

What interventions are being tested in trial NCT00443001?

The interventions under investigation include: Non invasive blood pressure monitor (DEVICE).

Who is sponsoring clinical trial NCT00443001?

This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00443001's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00443001, the US trial registry maintained by the National Library of Medicine. NCT00443001 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.